Yemaachi, Africa’s Cancer Research Company, Raises Seed Round To Diversify Genomic Datasets & Advance Precision Oncology Globally

ACCRA, Ghana–(BUSINESS WIRE)–Yemaachi Biotech, a cancer research and diagnostics company headquartered in Accra, Ghana with offices in Washington, DC, announced today the close of a $3 million seed round to advance its mission of diversifying precision oncology globally. V8 Capital led the round, with LifeLine Family Heritage Fund, Y Combinator, Tencent, LoftyInc Capital, VestedWorld, V Square Capital and Ethan Perlstein also participating.

“The breadth of expertise of Yemaachi’s highly talented founding team, the clinical partnerships they have already formed, and their focus on leveraging the vast untapped resource of African genetic diversity to discover the next generation of cancer diagnostics and therapeutics makes them a very exciting and valuable investment for us”

Tobi Oke, Managing Partner at V8 Capital Partners

Read full press release here.